300 related articles for article (PubMed ID: 32633857)
1. Overcoming vincristine resistance in cancer: Computational design and discovery of piperine-inspired P-glycoprotein inhibitors.
Syed SB; Lin SY; Arya H; Fu IH; Yeh TK; Charles MRC; Periyasamy L; Hsieh HP; Coumar MS
Chem Biol Drug Des; 2021 Jan; 97(1):51-66. PubMed ID: 32633857
[TBL] [Abstract][Full Text] [Related]
2. Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer.
Syed SB; Arya H; Fu IH; Yeh TK; Periyasamy L; Hsieh HP; Coumar MS
Sci Rep; 2017 Aug; 7(1):7972. PubMed ID: 28801675
[TBL] [Abstract][Full Text] [Related]
3. Selective Cytotoxicity of Piperine Over Multidrug Resistance Leukemic Cells.
Quarti J; Torres DNM; Ferreira E; Vidal RS; Casanova F; Chiarini LB; Fialho E; Rumjanek VM
Molecules; 2021 Feb; 26(4):. PubMed ID: 33578817
[TBL] [Abstract][Full Text] [Related]
4. Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells.
Li S; Lei Y; Jia Y; Li N; Wink M; Ma Y
Phytomedicine; 2011 Dec; 19(1):83-7. PubMed ID: 21802927
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment.
Katiyar SS; Muntimadugu E; Rafeeqi TA; Domb AJ; Khan W
Drug Deliv; 2016 Sep; 23(7):2608-2616. PubMed ID: 26036652
[TBL] [Abstract][Full Text] [Related]
6. Capsaicin and Piperine Can Overcome Multidrug Resistance in Cancer Cells to Doxorubicin.
Li H; Krstin S; Wang S; Wink M
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498663
[TBL] [Abstract][Full Text] [Related]
7. A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitors.
Singh DV; Godbole MM; Misra K
J Mol Model; 2013 Jan; 19(1):227-38. PubMed ID: 22864626
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Traditional Chinese Medicine on P-Glycoprotein-Mediated Multidrug Resistance and Approaches for Studying the Herb-P-Glycoprotein Interactions.
Cao Y; Shi Y; Cai Y; Hong Z; Chai Y
Drug Metab Dispos; 2020 Oct; 48(10):972-979. PubMed ID: 32816867
[TBL] [Abstract][Full Text] [Related]
9. Enhancing Activity of Anticancer Drugs in Multidrug Resistant Tumors by Modulating P-Glycoprotein through Dietary Nutraceuticals.
Khan M; Maryam A; Mehmood T; Zhang Y; Ma T
Asian Pac J Cancer Prev; 2015; 16(16):6831-9. PubMed ID: 26514453
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity and comparative binding mechanism of piperine with human serum albumin and α-1-acid glycoprotein.
Yeggoni DP; Rachamallu A; Kallubai M; Subramanyam R
J Biomol Struct Dyn; 2015; 33(6):1336-51. PubMed ID: 25054206
[TBL] [Abstract][Full Text] [Related]
11. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
[TBL] [Abstract][Full Text] [Related]
12. Piperine as a Potential Anti-cancer Agent: A Review on Preclinical Studies.
Manayi A; Nabavi SM; Setzer WN; Jafari S
Curr Med Chem; 2018; 25(37):4918-4928. PubMed ID: 28545378
[TBL] [Abstract][Full Text] [Related]
13. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening of Piperine analogs as Survivin inhibitors and their molecular interaction analysis by using consensus docking, MD simulation, MMPB/GBSA and alanine scanning techniques.
Sattarinezhad E; Bordbar AK; Fani N
J Biomol Struct Dyn; 2017 Jun; 35(8):1824-1832. PubMed ID: 27576945
[No Abstract] [Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance in SGC7901/VCR cells by PPARgamma activation by troglitazone.
Chen Q; Zhou J; Jiang C; Chen J
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):326-31. PubMed ID: 20556576
[TBL] [Abstract][Full Text] [Related]
16. In silico comparisons between natural inhibitors of ABCB1/P-glycoprotein to overcome doxorubicin-resistance in the NCI/ADR-RES cell line.
Morsy MA; El-Sheikh AAK; Ibrahim ARN; Khedr MA; Al-Taher AY
Eur J Pharm Sci; 2018 Jan; 112():87-94. PubMed ID: 29133241
[TBL] [Abstract][Full Text] [Related]
17. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
18. In Silico and In Vitro Investigation of the Piperine's Male Contraceptive Effect: Docking and Molecular Dynamics Simulation Studies in Androgen-Binding Protein and Androgen Receptor.
Chinta G; Ramya Chandar Charles M; Klopčič I; Sollner Dolenc M; Periyasamy L; Selvaraj Coumar M
Planta Med; 2015 Jul; 81(10):804-12. PubMed ID: 26039262
[TBL] [Abstract][Full Text] [Related]
19. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
De Vera AA; Gupta P; Lei Z; Liao D; Narayanan S; Teng Q; Reznik SE; Chen ZS
Cancer Lett; 2019 Feb; 442():91-103. PubMed ID: 30391357
[TBL] [Abstract][Full Text] [Related]
20. Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
Sangwan PL; Koul JL; Koul S; Reddy MV; Thota N; Khan IA; Kumar A; Kalia NP; Qazi GN
Bioorg Med Chem; 2008 Nov; 16(22):9847-57. PubMed ID: 18848780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
